Deutsche Bank’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.03M | Buy |
318,653
+989
| +0.3% | +$9.42K | ﹤0.01% | 1465 |
|
|
2025
Q1 | $3.32M | Buy |
317,664
+246,703
| +348% | +$2.58M | ﹤0.01% | 1437 |
|
|
2024
Q4 | $1.67M | Buy |
70,961
+24,104
| +51% | +$568K | ﹤0.01% | 1940 |
|
|
2024
Q3 | $1.68M | Buy |
46,857
+12,817
| +38% | +$460K | ﹤0.01% | 1832 |
|
|
2024
Q2 | $1.2M | Buy |
34,040
+6,962
| +26% | +$246K | ﹤0.01% | 1872 |
|
|
2024
Q1 | $769K | Buy |
27,078
+6,177
| +30% | +$175K | ﹤0.01% | 2114 |
|
|
2023
Q4 | $278K | Sell |
20,901
-522
| -2% | -$6.94K | ﹤0.01% | 2644 |
|
|
2023
Q3 | $192K | Buy |
21,423
+4,031
| +23% | +$36.1K | ﹤0.01% | 2783 |
|
|
2023
Q2 | $196K | Sell |
17,392
-2,125
| -11% | -$23.9K | ﹤0.01% | 2885 |
|
|
2023
Q1 | $225K | Buy |
19,517
+1,117
| +6% | +$12.9K | ﹤0.01% | 2940 |
|
|
2022
Q4 | $213K | Buy |
18,400
+4,209
| +30% | +$48.8K | ﹤0.01% | 2934 |
|
|
2022
Q3 | $180K | Sell |
14,191
-58
| -0.4% | -$736 | ﹤0.01% | 2981 |
|
|
2022
Q2 | $98K | Sell |
14,249
-2,060
| -13% | -$14.2K | ﹤0.01% | 3509 |
|
|
2022
Q1 | $157K | Sell |
16,309
-1,938
| -11% | -$18.7K | ﹤0.01% | 3359 |
|
|
2021
Q4 | $217K | Buy |
18,247
+974
| +6% | +$11.6K | ﹤0.01% | 3317 |
|
|
2021
Q3 | $281K | Sell |
17,273
-557
| -3% | -$9.06K | ﹤0.01% | 3355 |
|
|
2021
Q2 | $375K | Buy |
17,830
+8,228
| +86% | +$173K | ﹤0.01% | 3384 |
|
|
2021
Q1 | $149K | Sell |
9,602
-2,282
| -19% | -$35.4K | ﹤0.01% | 3739 |
|
|
2020
Q4 | $250K | Buy |
+11,884
| New | +$250K | ﹤0.01% | 3297 |
|